Vertex Pharmaceuticals (VRTX) Asset Utilization Ratio (2010 - 2026)

Vertex Pharmaceuticals' Asset Utilization Ratio history runs 17 years deep, the most recent figure standing at 0.47 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 4.1% year-over-year to 0.47; the TTM figure through Mar 2026 stood at 0.47 (down 4.1% YoY), while the FY2025 annual figure was 0.5, up 2.32% from the prior year.
• Asset Utilization Ratio was 0.47 for Q1 2026 at Vertex Pharmaceuticals, down from 0.48 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.57 in Q1 2022 to a low of 0.44 in Q1 2024.
• Historically, Asset Utilization Ratio has averaged 0.49 across 5 years, with a median of 0.49 in 2025.
• The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio slipped 14.85% in 2023, then rose 11.94% in 2025.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.51 in 2022, then retreated by 13.35% to 0.44 in 2023, then climbed by 10.87% to 0.49 in 2024, then fell by 3.46% to 0.48 in 2025, then dropped by 1.36% to 0.47 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.47 (Q1 2026), 0.48 (Q4 2025), and 0.48 (Q3 2025), per Business Quant data.